Cargando…

How many cases of disease in a pedigree imply familial disease?

The ability to perform whole‐exome and, increasingly, whole‐genome sequencing on large numbers of individuals has led to increased efforts to identify rare genetic variants that affect the risk of both common and rare diseases. In such applications, it is important to identify families that are segr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudbridge, Frank, Brown, Suzanne J., Ward, Lynley, Wilson, Scott G., Walsh, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813157/
https://www.ncbi.nlm.nih.gov/pubmed/29058319
http://dx.doi.org/10.1111/ahg.12222
_version_ 1783300136541093888
author Dudbridge, Frank
Brown, Suzanne J.
Ward, Lynley
Wilson, Scott G.
Walsh, John P.
author_facet Dudbridge, Frank
Brown, Suzanne J.
Ward, Lynley
Wilson, Scott G.
Walsh, John P.
author_sort Dudbridge, Frank
collection PubMed
description The ability to perform whole‐exome and, increasingly, whole‐genome sequencing on large numbers of individuals has led to increased efforts to identify rare genetic variants that affect the risk of both common and rare diseases. In such applications, it is important to identify families that are segregating the rare variants of interest. For rare diseases or rare familial forms of common diseases, pedigrees with multiple affected members are clearly harbouring risk variants. For more common diseases, however, it may be unclear whether a family with a few affected members is segregating a familial disease, is the result of multiple sporadic cases, or is a mixture of familial cases and phenocopies. We provide calculations for the probability that a family is harbouring familial disease, presented in general terms that admit working guidelines for selecting families for current sequencing studies. Using examples motivated by our own studies of thyroid cancer and published studies of colorectal cancer, we show that for common diseases, families with exactly two affected first‐degree relatives have only a moderate probability of segregating familial disease, but this probability is higher for families with three or more affected relatives, and those families should therefore be prioritised in sequencing studies.
format Online
Article
Text
id pubmed-5813157
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58131572018-02-21 How many cases of disease in a pedigree imply familial disease? Dudbridge, Frank Brown, Suzanne J. Ward, Lynley Wilson, Scott G. Walsh, John P. Ann Hum Genet Short Communications The ability to perform whole‐exome and, increasingly, whole‐genome sequencing on large numbers of individuals has led to increased efforts to identify rare genetic variants that affect the risk of both common and rare diseases. In such applications, it is important to identify families that are segregating the rare variants of interest. For rare diseases or rare familial forms of common diseases, pedigrees with multiple affected members are clearly harbouring risk variants. For more common diseases, however, it may be unclear whether a family with a few affected members is segregating a familial disease, is the result of multiple sporadic cases, or is a mixture of familial cases and phenocopies. We provide calculations for the probability that a family is harbouring familial disease, presented in general terms that admit working guidelines for selecting families for current sequencing studies. Using examples motivated by our own studies of thyroid cancer and published studies of colorectal cancer, we show that for common diseases, families with exactly two affected first‐degree relatives have only a moderate probability of segregating familial disease, but this probability is higher for families with three or more affected relatives, and those families should therefore be prioritised in sequencing studies. John Wiley and Sons Inc. 2017-10-23 2018-03 /pmc/articles/PMC5813157/ /pubmed/29058319 http://dx.doi.org/10.1111/ahg.12222 Text en © 2017 The Authors. Annals of Human Genetics published by University College London (UCL) and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Dudbridge, Frank
Brown, Suzanne J.
Ward, Lynley
Wilson, Scott G.
Walsh, John P.
How many cases of disease in a pedigree imply familial disease?
title How many cases of disease in a pedigree imply familial disease?
title_full How many cases of disease in a pedigree imply familial disease?
title_fullStr How many cases of disease in a pedigree imply familial disease?
title_full_unstemmed How many cases of disease in a pedigree imply familial disease?
title_short How many cases of disease in a pedigree imply familial disease?
title_sort how many cases of disease in a pedigree imply familial disease?
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813157/
https://www.ncbi.nlm.nih.gov/pubmed/29058319
http://dx.doi.org/10.1111/ahg.12222
work_keys_str_mv AT dudbridgefrank howmanycasesofdiseaseinapedigreeimplyfamilialdisease
AT brownsuzannej howmanycasesofdiseaseinapedigreeimplyfamilialdisease
AT wardlynley howmanycasesofdiseaseinapedigreeimplyfamilialdisease
AT wilsonscottg howmanycasesofdiseaseinapedigreeimplyfamilialdisease
AT walshjohnp howmanycasesofdiseaseinapedigreeimplyfamilialdisease